The deal involved the purchase of a majority stake from Italy’s KOS Group and fresh equity injection into the company
A prominent healthcare leader Commander Navneet Bali has been appointed as Group Chief Executive Officer (CEO) of ClearMedi Healthcare which is cancer-focused healthcare service provider.
In a move marking Morgan Stanley’s debut in the Indian healthcare landscape, the global financial powerhouse has acquired a majority stake in ClearMedi Healthcare. Under the leadership of Commander Bali Morgan Stanley-backed ClearMedi Healthcare is all set to chart an ambitious path toward solidifying its position in the industry.
Commander Bali, with an illustrious 25-year career in the Indian Navy and successful leadership roles at Narayana Health and IOSPL, is well-poised to lead ClearMedi Healthcare to new heights of success.
Dr Shashi Baliyan, Founder of ClearMedi Healthcare, expressed enthusiasm about this groundbreaking collaboration, stating, “Morgan Stanley’s entry into the Indian healthcare sector signifies a transformative moment for our industry. As we continue to expand and provide high-quality healthcare solutions to our patients, Commander Navneet Bali’s visionary leadership, coupled with Morgan Stanley’s support, will play a pivotal role in shaping our company’s future.”
Commander Bali said, “I am honored to join ClearMedi Healthcare as the Group CEO and be part of an organization committed to making a meaningful impact in the healthcare landscape. Together with our talented team, we will drive innovation, foster growth, and ensure that ClearMedi Healthcare remains a beacon of excellence in the industry.”
ClearMedi Healthcare is a joint venture between Medipass, a subsidiary of La Repubblica Group in Italy, KOS S.p.A. in Italy, and Clearview Healthcare India. Founded in 2010 by Shashi Kant Baliyan, ClearMedi Healthcare manages complex clinical services, including oncology, nuclear medicine, and radiology, and operates standalone super specialty hospitals with over 350 hospital beds across different locations. ClearMedi runs its facilities in eight states and a union territory and has emerged as a trusted leader in the healthcare sector, particularly in providing cancer care services.
Morgan Stanley PE Asia’s acquisition of a controlling stake in ClearMedi Healthcare, a Delhi-NCR headquartered chain of oncology hospitals and radiation therapy centers, valued at approximately $35 million (Rs 285 crore), is a testament to the global financial giant’s commitment to the Indian healthcare sector. The deal involved the purchase of a majority stake from Italy’s KOS Group and fresh equity injection into the company.